John Duan

Title: John Duan: Innovator in Oncology

Introduction

John Duan is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of oncology through his innovative work. His research focuses on improving the administration and effectiveness of cancer treatments.

Latest Patents

John Duan holds a patent for "Cabozantinib compositions and methods of use." This invention relates to oral compositions that comprise cabozantinib salts and at least one pharmaceutically acceptable excipient. The methods outlined in the patent aim to increase the oral bioavailability of cabozantinib while reducing the adverse events associated with its oral administration. Additionally, the invention includes methods for preparing cabozantinib lauryl sulfate salts.

Career Highlights

John Duan is currently associated with Handa Oncology, LLC, where he continues to advance his research in oncology. His work is pivotal in developing more effective cancer therapies that can improve patient outcomes.

Collaborations

Some of his notable coworkers include Fang-Yu Liu and Kc Sung, who contribute to the collaborative efforts in their research endeavors.

Conclusion

John Duan's innovative contributions to oncology through his patent on cabozantinib compositions highlight his commitment to improving cancer treatment methodologies. His work exemplifies the importance of innovation in the medical field.